NeuroGlove Anxiety and Depression Study

Launched by NEUROGLOVE LLC · Sep 26, 2023

Keywords

ClinConnect Summary

The NeuroGlove Anxiety and Depression Study is a clinical trial aimed at understanding how the NeuroGlove device can help people who suffer from anxiety and depression. This study will include 10 adult participants, aged between 18 and 85, who are experiencing symptoms that affect their daily lives. To join, you must be able to give your consent, have a diagnosis of anxiety and/or depression, and be able to engage with the study without any severe physical limitations that could affect your ability to use the device.

If you participate in this study, you’ll be using the NeuroGlove in the comfort of your own home. The goal is to see if this device helps improve your symptoms and overall quality of life. It's also important to know that if you're currently involved in another clinical trial, you won't be able to participate in this one. This study is currently recruiting participants, so if you or someone you know fits the eligibility criteria, it could be a great opportunity to seek help for anxiety and depression.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
• • Men and women ≥18 and \<85 years of age.
• • Carry an active diagnosis of anxiety and/or depression.
• • Suffer from anxiety and/or depression symptoms that impact subject's daily activities and quality of life.
• Exclusion Criteria:
• • Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
• • The subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
• • Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)